Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot O75443: Variant p.Arg371Gly

Alpha-tectorin
Gene: TECTA
Feedback?
Variant information Variant position: help 371 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LB/B The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Arginine (R) to Glycine (G) at position 371 (R371G, p.Arg371Gly). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and basic (R) to glycine (G) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 371 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 2155 The length of the canonical sequence.
Location on the sequence: help QCLQTSSLPFFSVEAKNEHR R GSAVSWVKELSVEVNGYKIL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         QCLQTSSLPFFSVEAKNEHRRGSAVSWVKELSVEVNGYKIL

Mouse                         QCLQTSSLPFFSVEAKNEHRGGSAVSWVKELSVEVNGYKIL

Chicken                       QCWPGSQLPYFNVEAKNE-RGGSSVSWAEDIFVEVYRHKIV

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 23 – 2091 Alpha-tectorin
Domain 320 – 500 VWFD 1
Disulfide bond 322 – 461
Disulfide bond 344 – 499



Literature citations
Mutations in the human alpha-tectorin gene cause autosomal dominant non-syndromic hearing impairment.
Verhoeven K.; Van Laer L.; Kirschhofer K.; Legan P.K.; Hughes D.C.; Schatteman I.; Verstreken M.; Van Hauwe P.; Coucke P.; Chen A.; Smith R.J.H.; Somers T.; Offeciers F.E.; Van de Heyning P.; Richardson G.P.; Wachtler F.; Kimberling W.J.; Willems P.J.; Govaerts P.J.; Van Camp G.;
Nat. Genet. 19:60-62(1998)
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS DFNA12 PHE-1820; ASP-1824 AND CYS-1870; VARIANTS GLY-371; ALA-932 AND ASN-1724; Alpha-tectorin involvement in hearing disabilities: one gene -- two phenotypes.
Balciuniene J.; Dahl N.; Jalonen P.; Verhoeven K.; Van Camp G.; Borg E.; Pettersson U.; Jazin E.E.;
Hum. Genet. 105:211-216(1999)
Cited for: VARIANT DFNA12 SER-1057; VARIANTS GLY-371; ALA-932 AND THR-2100;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.